Moreover, patients with T2DM have an increased hepatic glucose production and insulin insensitivity in skeletal muscle and adipose tissue or a combination of both and long-term persistent inflammation, all of which progressively disrupt control of glucose concentrations in blood and result in an occurrence of deleterious diabetic complications [72–74]. This evidence concerns the gene INS and type 2 diabetes mellitus.